Aperio Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $2.2M | Sell |
24,560
-8,913
| -27% | -$799K | 0.01% | 1192 |
|
|
2020
Q3 | $3.46M | Buy |
33,473
+9,684
| +41% | +$1M | 0.01% | 880 |
|
|
2020
Q2 | $1.88M | Buy |
23,789
+1,190
| +5% | +$94.1K | 0.01% | 1137 |
|
|
2020
Q1 | $1.31M | Buy |
22,599
+1,788
| +9% | +$103K | 0.01% | 1190 |
|
|
2019
Q4 | $1.12M | Buy |
20,811
+1,226
| +6% | +$66.2K | ﹤0.01% | 1378 |
|
|
2019
Q3 | $1.02M | Buy |
19,585
+1,583
| +9% | +$82.8K | ﹤0.01% | 1380 |
|
|
2019
Q2 | $870K | Sell |
18,002
-1,508
| -8% | -$72.9K | ﹤0.01% | 1469 |
|
|
2019
Q1 | $986K | Sell |
19,510
-888
| -4% | -$44.9K | ﹤0.01% | 1380 |
|
|
2018
Q4 | $1.21M | Buy |
20,398
+4,405
| +28% | +$261K | 0.01% | 1206 |
|
|
2018
Q3 | $1.05M | Buy |
15,993
+822
| +5% | +$54.1K | ﹤0.01% | 1377 |
|
|
2018
Q2 | $766K | Buy |
15,171
+366
| +2% | +$18.5K | ﹤0.01% | 1524 |
|
|
2018
Q1 | $779K | Buy |
14,805
+1,497
| +11% | +$78.8K | ﹤0.01% | 1463 |
|
|
2017
Q4 | $618K | Buy |
13,308
+465
| +4% | +$21.6K | ﹤0.01% | 1606 |
|
|
2017
Q3 | $519K | Buy |
12,843
+1,199
| +10% | +$48.5K | ﹤0.01% | 1645 |
|
|
2017
Q2 | $395K | Buy |
11,644
+589
| +5% | +$20K | ﹤0.01% | 1758 |
|
|
2017
Q1 | $321K | Sell |
11,055
-592
| -5% | -$17.2K | ﹤0.01% | 1788 |
|
|
2016
Q4 | $382K | Buy |
11,647
+1,680
| +17% | +$55.1K | ﹤0.01% | 1670 |
|
|
2016
Q3 | $314K | Sell |
9,967
-1,358
| -12% | -$42.8K | ﹤0.01% | 1687 |
|
|
2016
Q2 | $318K | Buy |
11,325
+783
| +7% | +$22K | ﹤0.01% | 1636 |
|
|
2016
Q1 | $383K | Buy |
10,542
+2,154
| +26% | +$78.3K | ﹤0.01% | 1503 |
|
|
2015
Q4 | $336K | Buy |
8,388
+1,090
| +15% | +$43.7K | ﹤0.01% | 1546 |
|
|
2015
Q3 | $208K | Buy |
7,298
+981
| +16% | +$28K | ﹤0.01% | 1754 |
|
|
2015
Q2 | $208K | Buy |
+6,317
| New | +$208K | ﹤0.01% | 1838 |
|